Moreover, blockade of the PGE2 receptors EP2 and EP4 (EP2/EP4) with small molecule antagonists abrogated the suppressive effect of PGE2 on human TIL expansion from tumour tissue in response to IL-2 ex vivo (Fig. 2c and Extended Data Fig. 3c). The gene discussed is PTGER4; the disease is neoplasm.